Article

Oral ingestion of the environmental toxicant trichloroethylene in rats induces alterations in the gut microbiome: relevance to idiopathic Parkinson’s disease

2022-02-20

Abstract excerpt

Microbial alterations within the gut microbiome appear to be a common feature of individuals with Parkinson’s disease (PD), providing further evidence for the role of the gut-brain axis in PD development. As a major site of contact with the environment, questions have emerged surrounding the cause and effect of alterations to the gut microbiome by environmental contaminants associated with PD risk, such as pestici...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 61c64b0c-9c2b-5dc1-b29e-87f444f36dca
DOI: 10.1101/2022.02.19.481161

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Oral ingestion of the environmental toxicant trichloroethylene in rats induces alterations in the gut microbiome: relevance to idiopathic Parkinson’s diseaseDOI 10.1101/2022.02.19.481161Read

The industrial solvent trichloroethylene induces LRRK2 kinase activity and dopaminergic neurodegeneration in a rat model of Parkinson’s diseaseSemantic proximity Read

Clinical Phenotypes of Parkinson's Disease Associate with Distinct Gut Microbiota and Metabolome Enterotypes.Semantic proximity Read

Exploring environmental modifiers of LRRK2-associated Parkinson’s disease penetrance: An exposomics and metagenomics pilot study on household dustSemantic proximity Read

Implications of Parkinson’s disease-associated alterations in the oral and gut microbiome on vitamin B12 biosynthesis and levodopa bioavailabilitySemantic proximity Read

Ingestion of Poly-Ethylene Terephthalate Nanofragments Derived from Plastic Bottles Triggers Long-term Gut Inflammation and Microbiome Dysbiosis in MiceSemantic proximity Read

Enriched environmental conditions modify the gut microbiome composition and fecal markers of inflammation in Parkinson’s diseaseSemantic proximity Read

Identification of volatile metabolites produced from gut microbial levodopa metabolism using an untargeted metabolomics approachSemantic proximity Read

Relationship Between Gut Bacteria and Levodopa MetabolismSemantic proximity Read

Fecal microbiome alterations in treatment-naive de novo Parkinson’s diseaseSemantic proximity Read

Desulfovibrio Bacteria Are Associated With Parkinson’s DiseaseSemantic proximity Read

Dietary fibre deprivation and bacterial curli exposure shift gut microbiome and exacerbate Parkinson's disease-like pathologies in an alpha-synuclein-overexpressing mouseSemantic proximity Read

Gut bacterial tyrosine decarboxylase gene abundance associates with disease duration, medication exposure, and gastrointestinal symptoms in a longitudinal cohort of Parkinson’s disease patientsSemantic proximity Read